Physician profile
Mayank V Patel
NPI 1902804768
$2,392.33
in general payments reported to CMS, 2019-2025
13 companies · $39.87 in 2025
The $39.87 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $145 · 2021: $444 · 2022: $301 · 2023: $422 · 2024: $792 · 2025: $39.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,253.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $595.67 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $447.58 | 2023-2025 | Jeti Peripheral Catheter, Esprit, Perclose Prostyle |
| Boston Scientific Corporation | $265.76 | 2021-2022 | |
| Tactile Systems Technology INC | $216.20 | 2021-2024 | Flexitouch Plus, Entre Plus |
| W. L. Gore & Associates, INC. | $192.62 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $141.21 | 2024 | Rexulti |
| Medtronic, INC. | $118.04 | 2022-2024 | Stealthstation S8 Platform |
| Avanir Pharmaceuticals, INC. | $115.00 | 2019 | |
| Medtronic Vascular, INC. | $111.70 | 2019 | |
| Advanced Oxygen Therapy INC. | $73.45 | 2020 | |
| Organogenesis INC. | $71.60 | 2020 | |
| Philips North America LLC | $22.01 | 2019 | |
| Merck Sharp & Dohme LLC | $21.49 | 2025 | Gardasil 9, Vaxneuvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayank Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.